Bomedemstat — Drug Intelligence | 3 EU Trials

Filter these 3 trials by condition, phase, country and more.

3 Registered trials

2 Recruiting

1 Completed trials

1 Sponsors

12 Countries

Phase III

Phase III: 3

Oversight events:

4 temporary halts 1 urgent safety measure across 2 trials

Indications tested

3 total

Bomedemstat vs Hydroxyurea for Essential Thrombocythemia Recruiting

2023-505232-36-00 Phase III 9 countries Merck Sharp & Dohme LLC
A clinical study of bomedemstat for people in a prior bomedemstat study Recruiting

2023-506996-89-00 Phase III 1 country Merck Sharp & Dohme LLC
Bomedemstat vs Best Available Therapy (BAT) for Essential Thrombocythemia Ended

2023-504865-21-00 Phase III 10 countries Merck Sharp & Dohme LLC

Showing 1–3 of 3 trials